Flexion Therapeutics, Inc. Assets, Fair Value Disclosure
Flexion Therapeutics, Inc. had Assets, Fair Value Disclosure of $124.14 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2020-03-12
- 2019-12-31: Assets, Fair Value Disclosure $124.14M.
- 2018-12-31: Assets, Fair Value Disclosure $229.29M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2019-12-31 | $124.14M 10-K · filed 2020-03-12 |
| 2018-12-31 | $229.29M 10-K · filed 2020-03-12 |